“targeting design” of nanoparticles in tumor therapy

HIGHLIGHTS

• who: Tingting Yang and colleagues from the School of Basic Medical Sciences, Henan University of Science and Technology, Luoyang, China have published the Article: u201cTargeting Designu201d of Nanoparticles in Tumor Therapy, in the Journal: Pharmaceutics 2022, 14, 1919. of /2022/
• what: With the further study of targeted NPs and the in-depth research on targeted NPs, a variety of different NP drugs have been approved by the US Food and Drug Administration (FDA) or are in clinical trials.
• how: The results showed that the overall viability of mice bearing in situ glioblastoma was . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.